Insulin therapy for the critically ill patient.
暂无分享,去创建一个
[1] R. Bouillon,et al. Intensive insulin therapy in critically ill patients - Reply , 2002 .
[2] R. Dittus,et al. Protocol-driven care in the intensive care unit: a tool for quality , 2001, Critical care.
[3] H. Knobler,et al. The role of hyperglycemia in acute stroke. , 2001, Archives of neurology.
[4] U. Das. Insulin and the critically ill , 2002, Critical care.
[5] B A Mizock,et al. Alterations in fuel metabolism in critical illness: hyperglycaemia. , 2001, Best practice & research. Clinical endocrinology & metabolism.
[6] L. Piegas,et al. Metabolic Modulation of Acute Myocardial Infarction The ECLA Glucose-Insulin-Potassium Pilot Trial , 1998 .
[7] C. Bolton,et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. , 1987, Brain : a journal of neurology.
[8] F. Visser,et al. Insulin: a wonder drug in the critically ill? , 2002, Critical care.
[9] R. Venn. Paper reports overview: Sepsis, insulin and noninvasive ventilation , 2002, Critical Care.
[10] H. Gerstein,et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.
[11] D. Chinkes,et al. Association of hyperglycemia with increased mortality after severe burn injury. , 2001, The Journal of trauma.
[12] F. Leijten,et al. Critical illness polyneuropathy a review of the literature, definition and pathophysiology , 1994, Clinical Neurology and Neurosurgery.
[13] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[14] J. Parrillo. Pathogenetic mechanisms of septic shock. , 1993, The New England journal of medicine.
[15] Miet Schetz,et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.
[16] O. Ljungqvist,et al. Insulin resistance and elective surgery. , 2000, Surgery.
[17] N R Webster,et al. Increased mortality associated with growth hormone treatment in critically ill adults. , 1999, The New England journal of medicine.
[18] J. Vincent. Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology , 2001, Critical care.
[19] C. Bolton,et al. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. , 1996, Critical care medicine.
[20] D. Yellon,et al. Myocardial Protection by Insulin at Reperfusion Requires Early Administration and Is Mediated via Akt and p70s6 Kinase Cell-Survival Signaling , 2001, Circulation research.